SCHEMBL5141277

SCHEMBL5141277

COc1cccc(-c2nc([AsH2])nc(O)c2C#N)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 8/20 0.58
ADORA1 P30542 7/20 0.58
ADORA2B P29275 5/20 0.58
RXFP1 Q9HBX9 2/20 0.54
MAPT P10636 1/20 0.54
HPGD P15428 2/20 0.53
HTT P42858 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
TP53 P04637 1/20 0.52
KDM4E B2RXH2 2/20 0.48
GLA P06280 1/20 0.48
LMNA P02545 1/20 0.47
SQOR Q9Y6N5 1/20 0.46
MAPK8 P45983 1/20 0.44
MAPK9 P45984 1/20 0.44
MAPK10 P53779 1/20 0.44
KDM1A O60341 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904033 0.85 ADORA1 (0.77) ADORA2AADORA1ADORA2BRXFP1MAPT
SCHEMBL4421002 0.82 RXFP1 (0.61) ADORA2AADORA1ADORA2BRXFP1MAPT
SCHEMBL15286448 0.78 ADORA1 (0.67) ADORA2AADORA1ADORA2BRXFP1MAPT
SCHEMBL4908567 0.78 ADORA2A (0.57) ADORA2AADORA1ADORA2BRXFP1MAPT
SCHEMBL15286427 0.73 ADORA1 (0.67) ADORA2AADORA1ADORA2BRXFP1MAPT
SCHEMBL4905916 0.72 ADORA1 (0.77) ADORA2AADORA1ADORA2BRXFP1MAPT
SCHEMBL5937502 0.71 HPGD (0.74) ADORA2AADORA1ADORA2BRXFP1MAPT
SCHEMBL3369169 0.71 ADORA1 (0.71) ADORA2AADORA1ADORA2BRXFP1MAPT
SCHEMBL5744860 0.71 ADORA1 (0.60) ADORA2AADORA1ADORA2BRXFP1MAPT
SCHEMBL5501933 0.70 ADORA1 (0.64) ADORA2AADORA1ADORA2BRXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984377-A2 INHIBITORS OF TNF ALPHA , PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH Signal Pharmaceuticals LLC (US) 2008-10-29 EP disclosed
WO-2007084560-A2 INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2007-07-26 WO disclosed